Patents-Review.com
🔗 Permalink
Assignee profile:

UCB PHARMA S.A.

City:

Brussels

Country:

Belgium

Published Applications:

213

Last publication date:

2021-03-04

Patent Grants:

186

Last grant date:

2024-02-13

Quarterly UCB PHARMA S.A. Patent Applications

Top Inventors for applications by UCB PHARMA S.A.

These are the the leading inventors for applications assigned to UCB PHARMA S.A.:

Recent patent applications by UCB PHARMA S.A.

UCB PHARMA S.A. based in Brussels, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-03-04 ✅ Patent 11,896,667 granted on 2024-02-13
US20210060160A1
Human necessities

Treatment for bone diseases

 #2 | 2020-07-23 ✅ Patent 11,702,468 granted on 2023-07-18
US20200231664A1
Chemistry; metallurgy

Antibodies specific for sclerostin and methods for increasing bone mineralization

 #3 | 2019-05-09 ✅ Patent 11,339,214 granted on 2022-05-24
US20190135909A1
Chemistry; metallurgy

Protein purification

 #4 | 2018-06-21 ✅ Patent 10,799,583 granted on 2020-10-13
US20180169235A1
Human necessities

Treatment for bone diseases

 #5 | 2018-04-26 ✅ Patent 11,851,483 granted on 2023-12-26
US20180111986A1
Chemistry; metallurgy

Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen

 #6 | 2017-06-29
US20170182159A1
Human necessities

ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-6

 #7 | 2016-12-08 ✅ Patent 10,017,575 granted on 2018-07-10
US20160355598A1
Chemistry; metallurgy

Antibody molecules having specificity for human OX40

 #8 | 2016-10-27 ✅ Patent 9,828,438 granted on 2017-11-28
US20160311930A1
Chemistry; metallurgy

Dual specificity antibody fusions

 #9 | 2016-07-14 ✅ Patent 9,550,973 granted on 2017-01-24
US20160200810A1
Chemistry; metallurgy

Bacterial host strain

 #10 | 2016-06-30 ✅ Patent 9,791,462 granted on 2017-10-17
US20160187357A1
Physics

Compositions and methods for increasing bone mineralization

 #11 | 2016-06-30 ✅ Patent 9,630,948 granted on 2017-04-25
US20160185761A1
Chemistry; metallurgy

Compounds for enhancing the cognitive function

 #12 | 2016-04-21 ✅ Patent 10,189,897 granted on 2019-01-29
US20160108119A1
Chemistry; metallurgy

Protein purification

 #13 | 2016-02-11 ✅ Patent 9,631,015 granted on 2017-04-25
US20160039929A1
Chemistry; metallurgy

Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6

 #14 | 2015-07-09 ✅ Patent 9,657,095 granted on 2017-05-23
US20150191537A1
Chemistry; metallurgy

Antibodies specific for sclerostin and methods for increasing bone mineralization

 #15 | 2015-06-18 ✅ Patent 9,493,559 granted on 2016-11-15
US20150166652A1
Chemistry; metallurgy

Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity

 #16 | 2015-06-18 ✅ Patent 9,493,558 granted on 2016-11-15
US20150166651A1
Chemistry; metallurgy

Bacterial host strain comprising a mutant SPR gene and a wild-type TSP gene

 #17 | 2015-05-14 ✅ Patent 9,587,227 granted on 2017-03-07
US20150132828A1
Chemistry; metallurgy

Bacterial host strain comprising a mutant spr gene and having reduced Tsp activity

 #18 | 2015-02-12 ✅ Patent 9,901,673 granted on 2018-02-27
US20150045734A1
Human necessities

Auto-injector

 #19 | 2015-01-08 ✅ Patent 9,067,930 granted on 2015-06-30
US20150011526A1
Chemistry; metallurgy

2-oxo-piperidinyl derivatives

 #20 | 2014-12-04 ✅ Patent 9,808,575 granted on 2017-11-07
US20140358085A1
Human necessities

Auto-injector

 #21 | 2014-12-04 ✅ Patent 9,878,092 granted on 2018-01-30
US20140358084A1
Human necessities

Auto-injector

 #22 | 2014-12-04 ✅ Patent 9,669,158 granted on 2017-06-06
US20140358083A1
Human necessities

Auto-injector

 #23 | 2014-12-04 ✅ Patent 9,764,084 granted on 2017-09-19
US20140358072A1
Human necessities

Auto-injector

 #24 | 2014-12-04 ✅ Patent 9,315,565 granted on 2016-04-19
US20140356911A1
Chemistry; metallurgy

Method for producing protein

 #25 | 2014-11-27 ✅ Patent 10,752,676 granted on 2020-08-25
US20140348844A1
Chemistry; metallurgy

Neutralising antibodies to the major exotoxins TCDA and TCDB of

#26 | 2014-11-20 ✅ Patent 8,986,954 granted on 2015-03-24
US20140342406A1
Chemistry; metallurgy

DNA encoding function modifying Na1.7 antibodies

 #27 | 2014-11-13 ✅ Patent 9,901,674 granted on 2018-02-27
US20140336588A1
Human necessities

Auto-injector

 #28 | 2014-11-13 ✅ Patent 9,795,734 granted on 2017-10-24
US20140336587A1
Human necessities

Auto-injector

 #29 | 2014-11-06 ✅ Patent 9,884,152 granted on 2018-02-06
US20140330207A1
Human necessities

Auto-injector

 #30 | 2014-11-06 ✅ Patent 10,258,740 granted on 2019-04-16
US20140330203A1
Human necessities

Auto-injector

 #31 | 2014-10-16 ✅ Patent 9,227,984 granted on 2016-01-05
US20140309222A1
Chemistry; metallurgy

Therapeutically active fused pyrimidine derivatives

 #32 | 2014-10-09 ✅ Patent 9,803,004 granted on 2017-10-31
US20140302033A1
Chemistry; metallurgy

Albumin binding antibodies and binding fragments thereof

 #33 | 2014-09-11 ✅ Patent 9,901,686 granted on 2018-02-27
US20140257192A1
Human necessities

Systems and methods for administering medication

 #34 | 2014-08-28 ✅ Patent 9,096,887 granted on 2015-08-04
US20140242625A1
Chemistry; metallurgy

Analytical method for fab and fab′ molecules

 #35 | 2014-07-10 ✅ Patent 9,309,327 granted on 2016-04-12
US20140194596A1
Chemistry; metallurgy

Dual specificity antibody fusions

 #36 | 2014-07-10 ✅ Patent 9,045,537 granted on 2015-06-02
US20140193403A1
Chemistry; metallurgy

Antibodies specific to IL-17A and IL-17F

 #37 | 2014-07-03
US20140186355A1
Chemistry; metallurgy

Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F

 #38 | 2014-06-26 ✅ Patent 9,394,361 granted on 2016-07-19
US20140178387A1
Chemistry; metallurgy

Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13

 #39 | 2014-05-29 ✅ Patent 8,957,218 granted on 2015-02-17
US20140148489A1
Chemistry; metallurgy

2-oxo-1-imidazolidinyl imidazothiadiazole derivatives

 #40 | 2014-05-22 ✅ Patent 9,725,516 granted on 2017-08-08
US20140141468A1
Chemistry; metallurgy

Bacterial host strain expressing recombinant DSBC

 #41 | 2014-03-20 ✅ Patent 10,208,349 granted on 2019-02-19
US20140080134A1
Chemistry; metallurgy

Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy

 #42 | 2014-03-06 ✅ Patent 9,034,600 granted on 2015-05-19
US20140065674A1
Chemistry; metallurgy

DNA encoding antibody molecules which bind IL-17A and IL-17F

 #43 | 2014-02-13
US20140044732A1
Chemistry; metallurgy

Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F

 #44 | 2014-01-23 ✅ Patent 9,096,668 granted on 2015-08-04
US20140024077A1
Chemistry; metallurgy

Methods for making antibody molecules having specificity for human IL-6

 #45 | 2013-12-12 ✅ Patent 9,428,570 granted on 2016-08-30
US20130330344A1
Chemistry; metallurgy

Antibody molecules having specificity for human OX40

 #46 | 2013-12-05 ✅ Patent 10,562,966 granted on 2020-02-18
US20130323236A1
Chemistry; metallurgy

Antibodies of the class IGG4

 #47 | 2013-11-14 ✅ Patent 10,472,426 granted on 2019-11-12
US20130302336A1
Chemistry; metallurgy

Disulfide stabilized DVD-Ig molecules

 #48 | 2013-11-07 ✅ Patent 9,029,392 granted on 2015-05-12
US20130296338A1
Chemistry; metallurgy

Quinoline derivatives as kinase inhibitors

 #49 | 2013-09-19 ✅ Patent 8,865,167 granted on 2014-10-21
US20130245229A1
Chemistry; metallurgy

Neutralising antibody molecules having specificity for human IL-17

 #50 | 2013-09-19 ✅ Patent 9,040,048 granted on 2015-05-26
US20130243772A1
Chemistry; metallurgy

Antibody molecules having specificity for human OX40

 #51 | 2013-09-05 ✅ Patent 9,120,860 granted on 2015-09-01
US20130230524A1
Chemistry; metallurgy

Protein involved in ovarian cancer

 #52 | 2013-08-08
US20130203968A1
Chemistry; metallurgy

ANTIBODY-BASED DIAGNOSTICS AND THERAPEUTICS

 #53 | 2013-07-18 ✅ Patent 9,309,280 granted on 2016-04-12
US20130184439A1
Chemistry; metallurgy

Protein purification

 #54 | 2013-07-18 ✅ Patent 8,722,353 granted on 2014-05-13
US20130183703A1
Physics

Analytical method for FAB and FAB′ molecules

 #55 | 2013-07-11 ✅ Patent 9,751,930 granted on 2017-09-05
US20130178607A1
Chemistry; metallurgy

Process for purifying proteins

 #56 | 2013-06-13 ✅ Patent 8,604,051 granted on 2013-12-10
US20130150573A1
Chemistry; metallurgy

Thieno-pyridine derivatives as MEK inhibitors

 #57 | 2013-05-16 ✅ Patent 8,986,685 granted on 2015-03-24
US20130121995A1
Human necessities

Compositions and methods for increasing bone mineralization

 #58 | 2013-05-02 ✅ Patent 9,045,529 granted on 2015-06-02
US20130108622A1
Chemistry; metallurgy

Disulfide stabilized antibodies and fragments thereof

 #59 | 2013-04-25 ✅ Patent 8,617,847 granted on 2013-12-31
US20130102030A1
Chemistry; metallurgy

Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F

 #60 | 2013-03-28 ✅ Patent 8,945,065 granted on 2015-02-03
US20130079717A1
Human necessities

Syringe safety assembly

 #61 | 2013-03-28 ✅ Patent 8,710,054 granted on 2014-04-29
US20130079330A1
Chemistry; metallurgy

Fused thiazole derivatives as kinase inhibitors

 #62 | 2013-03-14
US20130066054A1
Chemistry; metallurgy

MULTIVALENT ANTIBODIES

 #63 | 2013-03-14 ✅ Patent 9,011,856 granted on 2015-04-21
US20130064830A1
Chemistry; metallurgy

Antibodies specific for sclerostin and methods for increasing bone mineralization

 #64 | 2013-03-14 ✅ Patent 8,992,911 granted on 2015-03-31
US20130064829A1
Chemistry; metallurgy

Antibodies specific for sclerostin and methods for increasing bone mineralization

 #65 | 2013-02-28
US20130053549A1
Chemistry; metallurgy

Multivalent Antibodies

 #66 | 2013-02-21 ✅ Patent 8,784,823 granted on 2014-07-22
US20130045219A1
Chemistry; metallurgy

Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof

 #67 | 2013-01-17 ✅ Patent 8,637,543 granted on 2014-01-28
US20130018057A1
Chemistry; metallurgy

Quinoline derivatives as kinase inhibitors

 #68 | 2013-01-10 ✅ Patent 8,653,105 granted on 2014-02-18
US20130012517A1
Chemistry; metallurgy

Quinoline derivatives as kinase inhibitors

 #69 | 2013-01-10 ✅ Patent 8,957,090 granted on 2015-02-17
US20130012515A1
Chemistry; metallurgy

Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors

 #70 | 2012-12-27 ✅ Patent 8,394,822 granted on 2013-03-12
US20120329774A1
Chemistry; metallurgy

Thieno-pyridine derivatives as MEK inhibitors

 #71 | 2012-12-13
US20120316324A1
Chemistry; metallurgy

Disulfide Stabilised Multivalent Antibodies

 #72 | 2012-11-29 ✅ Patent 8,729,306 granted on 2014-05-20
US20120302790A1
Chemistry; metallurgy

Process for the preparation of nitrogen substituted aminotetralins derivatives

 #73 | 2012-11-29 ✅ Patent 8,969,037 granted on 2015-03-03
US20120301920A1
Chemistry; metallurgy

Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene

 #74 | 2012-11-22 ✅ Patent 8,969,039 granted on 2015-03-03
US20120295309A1
Chemistry; metallurgy

Bacterial host strain comprising a mutant SPR gene and having reduced TSP activity

 #75 | 2012-11-15 ✅ Patent 8,969,038 granted on 2015-03-03
US20120288894A1
Chemistry; metallurgy

Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity

 #76 | 2012-11-08
US20120283415A1
Chemistry; metallurgy

Multivalent Antibodies

 #77 | 2012-10-18 ✅ Patent 9,234,037 granted on 2016-01-12
US20120263728A1
Human necessities

Method to generate antibodies to ion channels

 #78 | 2012-10-18 ✅ Patent 9,067,995 granted on 2015-06-30
US20120263727A1
Chemistry; metallurgy

Method to generate antibodies to ion channels

 #79 | 2012-10-11 ✅ Patent 8,926,977 granted on 2015-01-06
US20120259096A1
Chemistry; metallurgy

Antibodies to the E1 extracellular loop of ion channels

 #80 | 2012-10-11 ✅ Patent 9,109,216 granted on 2015-08-18
US20120258492A1
Chemistry; metallurgy

Bacterial host strain

 #81 | 2012-09-27 ✅ Patent 8,642,641 granted on 2014-02-04
US20120245215A1
Chemistry; metallurgy

Co-crystals of pyrrolidinones

 #82 | 2012-09-27 ✅ Patent 8,822,508 granted on 2014-09-02
US20120245208A1
Chemistry; metallurgy

2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives

 #83 | 2012-08-23 ✅ Patent 8,518,943 granted on 2013-08-27
US20120214815A1
Chemistry; metallurgy

2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

 #84 | 2012-08-02 ✅ Patent 8,586,623 granted on 2013-11-19
US20120196866A1
Chemistry; metallurgy

2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

 #85 | 2012-07-19 ✅ Patent 8,486,662 granted on 2013-07-16
US20120183996A1
Human necessities

DNA encoding antibody molecules having specificity for human IL-6

 #86 | 2012-07-19 ✅ Patent 8,580,265 granted on 2013-11-12
US20120183558A1
Chemistry; metallurgy

Antibody molecules which bind IL-17A and IL-17F

 #87 | 2012-07-05
US20120171125A1
Human necessities

Methods for Enhancing the Cognitive Function

 #88 | 2012-05-24 ✅ Patent 8,435,761 granted on 2013-05-07
US20120129219A1
Chemistry; metallurgy

DNA encoding antibody molecules which bind human IL-17

 #89 | 2012-04-19
US20120095005A1
Chemistry; metallurgy

Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors

 #90 | 2012-04-19 ✅ Patent 8,828,719 granted on 2014-09-09
US20120094297A1
Chemistry; metallurgy

Method for producing protein

 #91 | 2012-03-29 ✅ Patent 8,513,284 granted on 2013-08-20
US20120077815A1
Chemistry; metallurgy

Fused pyridine and pyrazine derivatives as kinase inhibitors

 #92 | 2012-03-01 ✅ Patent 8,785,628 granted on 2014-07-22
US20120053167A1
Human necessities

Triazine derivatives as kinase inhibitors

 #93 | 2012-02-16 ✅ Patent 9,399,671 granted on 2016-07-26
US20120040401A1
Chemistry; metallurgy

Method for producing proteins

 #94 | 2012-02-16 ✅ Patent 8,563,036 granted on 2013-10-22
US20120040006A1
Human necessities

Pharmaceutical compositions comprising Brivaracetam

 #95 | 2012-02-09 ✅ Patent 8,492,416 granted on 2013-07-23
US20120035239A1
Chemistry; metallurgy

2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

 #96 | 2012-02-09 ✅ Patent 8,329,431 granted on 2012-12-11
US20120034656A1
Chemistry; metallurgy

Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17

 #97 | 2012-02-02 ✅ Patent 8,624,022 granted on 2014-01-07
US20120029188A1
Chemistry; metallurgy

Substituted aniline derivatives

 #98 | 2011-12-22
US20110313138A1
Chemistry; metallurgy

Method for Producing Proteins

 #99 | 2011-11-29 ✅ Patent 8,067,005 granted on 2011-11-29
US9719045
-

Divalent antibody fragments

 #100 | 2011-11-17 ✅ Patent 10,729,653 granted on 2020-08-04
US20110281929A1
Human necessities

Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives

Also check out UCB PHARMA, S.A.'s (Brussels, Belgium) applicant profile with 50 patent applications submitted.

AssigneeID:

3680 ⎘